Shares of Stoke Therapeutics Inc. (NASDAQ: STOK) surged more than 80% Tuesday after the company reported impressive data from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE